Everence Capital Management Inc. Takes Position in Waters Co. (NYSE:WAT)


Share on StockTwits

Everence Capital Management Inc. bought a new stake in Waters Co. (NYSE:WAT) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,646 shares of the medical instruments supplier’s stock, valued at approximately $468,000.

Several other institutional investors have also made changes to their positions in the company. Cetera Advisor Networks LLC grew its position in Waters by 1.9% in the 4th quarter. Cetera Advisor Networks LLC now owns 2,311 shares of the medical instruments supplier’s stock valued at $572,000 after buying an additional 43 shares during the last quarter. Savant Capital LLC grew its position in Waters by 3.8% in the 4th quarter. Savant Capital LLC now owns 1,239 shares of the medical instruments supplier’s stock valued at $307,000 after buying an additional 45 shares during the last quarter. CWM Advisors LLC grew its position in Waters by 1.3% in the 4th quarter. CWM Advisors LLC now owns 4,223 shares of the medical instruments supplier’s stock valued at $1,045,000 after buying an additional 53 shares during the last quarter. Meeder Asset Management Inc. boosted its position in shares of Waters by 6.5% during the 4th quarter. Meeder Asset Management Inc. now owns 1,182 shares of the medical instruments supplier’s stock worth $292,000 after purchasing an additional 72 shares in the last quarter. Finally, Treasurer of the State of North Carolina raised its stake in shares of Waters by 0.3% during the 4th quarter. Treasurer of the State of North Carolina now owns 23,465 shares of the medical instruments supplier’s stock worth $5,806,000 after buying an additional 80 shares during the last quarter. 91.80% of the stock is currently owned by institutional investors and hedge funds.

Shares of NYSE:WAT opened at $307.04 on Tuesday. Waters Co. has a 1 year low of $171.38 and a 1 year high of $309.65. The stock has a market capitalization of $19.05 billion, a P/E ratio of 38.24, a PEG ratio of 8.79 and a beta of 0.97. The stock has a 50-day simple moving average of $278.20 and a 200-day simple moving average of $250.19.

Waters (NYSE:WAT) last issued its earnings results on Monday, February 1st. The medical instruments supplier reported $3.65 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.89 by $0.76. Waters had a negative return on equity of 349.31% and a net margin of 22.61%. The business had revenue of $786.66 million during the quarter, compared to analysts’ expectations of $711.10 million. During the same quarter in the previous year, the business earned $3.20 EPS. Research analysts expect that Waters Co. will post 7.94 EPS for the current year.

Several research analysts have recently issued reports on the company. Smith Barney Citigroup raised Waters from a “sell” rating to a “neutral” rating in a research note on Wednesday, December 16th. Cleveland Research raised Waters from an “underperform” rating to a “buy” rating in a research note on Thursday, December 17th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised Waters from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $185.00 to $240.00 in a research note on Wednesday, December 16th. Wells Fargo & Company downgraded Waters from an “equal weight” rating to an “underweight” rating and set a $235.00 price target for the company. in a research note on Thursday, January 7th. Finally, Citigroup boosted their target price on shares of Waters from $250.00 to $300.00 in a research note on Wednesday, February 3rd. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $225.27.

In other news, Director Joann A. Reed sold 4,759 shares of the stock in a transaction that occurred on Tuesday, February 9th. The stock was sold at an average price of $282.39, for a total transaction of $1,343,894.01. Following the completion of the transaction, the director now directly owns 36,683 shares in the company, valued at approximately $10,358,912.37. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Joann A. Reed sold 1,600 shares of the company’s stock in a transaction that occurred on Friday, March 5th. The shares were sold at an average price of $263.31, for a total value of $421,296.00. 1.50% of the stock is owned by corporate insiders.

Waters Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Further Reading: Insider Trading

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.